Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES vs LYKA LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZIM LABORATORIES LYKA LABS ZIM LABORATORIES/
LYKA LABS
 
P/E (TTM) x 31.4 163.6 19.2% View Chart
P/BV x 2.1 8.7 24.5% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ZIM LABORATORIES   LYKA LABS
EQUITY SHARE DATA
    ZIM LABORATORIES
Mar-24
LYKA LABS
Mar-24
ZIM LABORATORIES/
LYKA LABS
5-Yr Chart
Click to enlarge
High Rs152144 105.7%   
Low Rs7389 82.0%   
Sales per share (Unadj.) Rs75.433.6 224.4%  
Earnings per share (Unadj.) Rs3.5-0.8 -446.8%  
Cash flow per share (Unadj.) Rs6.83.1 221.4%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs49.017.9 274.4%  
Shares outstanding (eoy) m48.7333.09 147.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.53.5 43.1%   
Avg P/E ratio x31.8-146.8 -21.6%  
P/CF ratio (eoy) x16.537.8 43.7%  
Price / Book Value ratio x2.36.5 35.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,4763,847 142.4%   
No. of employees `000NANA-   
Total wages/salary Rs m533268 199.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,6741,112 330.4%  
Other income Rs m5215 356.3%   
Total revenues Rs m3,7261,126 330.8%   
Gross profit Rs m413153 270.1%  
Depreciation Rs m160128 124.6%   
Interest Rs m6949 141.6%   
Profit before tax Rs m236-9 -2,531.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6417 379.1%   
Profit after tax Rs m172-26 -658.0%  
Gross profit margin %11.213.8 81.7%  
Effective tax rate %27.1-180.6 -15.0%   
Net profit margin %4.7-2.4 -199.2%  
BALANCE SHEET DATA
Current assets Rs m2,276507 449.4%   
Current liabilities Rs m1,594376 423.6%   
Net working cap to sales %18.611.7 158.7%  
Current ratio x1.41.3 106.1%  
Inventory Days Days1683 19.2%  
Debtors Days Days995886 112.3%  
Net fixed assets Rs m2,1921,061 206.6%   
Share capital Rs m487331 147.3%   
"Free" reserves Rs m1,900260 730.9%   
Net worth Rs m2,387591 404.1%   
Long term debt Rs m356429 83.0%   
Total assets Rs m4,4681,567 285.1%  
Interest coverage x4.40.8 545.7%   
Debt to equity ratio x0.10.7 20.5%  
Sales to assets ratio x0.80.7 115.9%   
Return on assets %5.41.4 373.4%  
Return on equity %7.2-4.4 -162.9%  
Return on capital %11.13.9 287.2%  
Exports to sales %73.90-   
Imports to sales %8.60-   
Exports (fob) Rs m2,714NA-   
Imports (cif) Rs m315NA-   
Fx inflow Rs m2,7740-   
Fx outflow Rs m3150-   
Net fx Rs m2,4590-   
CASH FLOW
From Operations Rs m16318 918.1%  
From Investments Rs m-730-95 769.5%  
From Financial Activity Rs m59520 3,048.3%  
Net Cashflow Rs m32-58 -55.2%  

Share Holding

Indian Promoters % 33.3 58.1 57.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.8 -  
FIIs % 0.0 0.2 -  
ADR/GDR % 0.0 0.0 -  
Free float % 66.7 41.9 159.3%  
Shareholders   17,716 28,943 61.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZIM LABORATORIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on ZIM LABORATORIES vs LYKA LABS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ZIM LABORATORIES vs LYKA LABS Share Price Performance

Period ZIM LABORATORIES LYKA LABS S&P BSE HEALTHCARE
1-Day 0.77% 1.81% 1.23%
1-Month -1.19% 4.75% -0.24%
1-Year -11.92% 9.72% 43.62%
3-Year CAGR -5.83% 5.24% 20.35%
5-Year CAGR 5.68% 53.27% 26.24%

* Compound Annual Growth Rate

Here are more details on the ZIM LABORATORIES share price and the LYKA LABS share price.

Moving on to shareholding structures...

The promoters of ZIM LABORATORIES hold a 33.3% stake in the company. In case of LYKA LABS the stake stands at 58.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ZIM LABORATORIES and the shareholding pattern of LYKA LABS.

Finally, a word on dividends...

In the most recent financial year, ZIM LABORATORIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

LYKA LABS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of ZIM LABORATORIES, and the dividend history of LYKA LABS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.